Customer story: Truely Contained Highly Potent Pharma Manufacturing

Looking to stay ahead of competitors in the market and a UK-based contract development and manufacturing organization (CDMO) — Penn Pharma (now PCI Pharma Services) identified an increased need in the solid dose oncology market for the outsourced optimization and production of high-quality, highly toxic drugs.